Zacks Investment Research
04 Aug 2026, 13:51 UTC · 4h ago
ImmunityBio (IBRX) Reports Q2 Loss, Beats Revenue Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
04 Aug 2026, 13:51 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ImmunityBio (IBRX) reported quarterly revenue of $51.24 million, surpassing the Zacks Consensus Estimate by 5.76% and significantly increasing from $26.42 million a year ago. — Strong revenue growth and a beat against expectations indicate positive commercial momentum for the company's products.
+0.40ImmunityBio reported a quarterly loss of $0.08 per share, beating the Zacks Consensus Estimate of a $0.09 loss. — While still operating at a loss, the earnings beat suggests better-than-expected cost management or revenue offset.
+0.20ImmunityBio currently holds a Zacks Rank #3 (Hold) based on recent earnings estimate revision trends. — A 'Hold' rating suggests a neutral outlook, offsetting some of the positivity from the immediate earnings beat.
+0.00Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
The company beat both earnings and revenue estimates for the quarter and has shown significant year-to-date stock growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
58m ago
